⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1597034 | 0.79 | — | — | |
| SCHEMBL15608469 | 0.79 | — | — | |
| SCHEMBL6254630 | 0.78 | — | — | |
| SCHEMBL7343188 | 0.77 | — | — | |
| SCHEMBL3933121 | 0.77 | — | — | |
| SCHEMBL14317076 | 0.77 | — | — | |
| Methyl Alcohol SCHEMBL3155059 | 0.77 | CHRM1 (0.41) | — | |
| SCHEMBL3651890 | 0.77 | — | — | |
| SCHEMBL1768268 | 0.77 | — | — | |
| SCHEMBL10832968 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024191956-A2 | MALODOR COUNTERACTING COMPOSITION | SKYESTER, INC. (US) | 2024-09-19 | — | — | WO | claimed |
| CN-114949255-B | Polysarcosine modified gold nano vesicle and preparation method and application thereof | 南京工业大学 | 2023-08-18 | — | — | CN | claimed |
| CN-114949255-A | Gold nano-vesicle modified by polymyosine and preparation method and application thereof | 南京工业大学 | 2022-08-30 | — | — | CN | claimed |
| US-20210138117-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2021-05-13 | — | — | US | claimed |
| US-10874766-B2 | Compounds and matrices for use in bone growth and repair | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2020-12-29 | — | — | US | claimed |
| CN-106432713-B | Poly- (proline-sarcosine) material of Thermo-sensitive and preparation method thereof | 河北大学 | 2018-12-25 | — | — | CN | claimed |
| US-20160038641-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2016-02-11 | — | — | US | claimed |
| US-20160001262-A1 | MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-07 | — | — | US | claimed |
| US-20150368354-A1 | METHODS FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-12-24 | — | — | US | claimed |
| EP-2953962-A1 | METHODS FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS | Agency For Science, Technology And Research (SG) | 2015-12-16 | — | — | EP | claimed |
| US-20150147243-A1 | MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-05-28 | — | — | US | claimed |
| EP-2855505-A1 | MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS FIELD | Agency For Science, Technology And Research (SG) | 2015-04-08 | — | — | EP | claimed |
| WO-2014123484-A1 | Methods For Reducing Aggregate Content In Protein Preparations | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-08-14 | — | — | WO | claimed |
| WO-2013180649-A1 | MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS FIELD | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-12-05 | — | — | WO | claimed |
| WO-2024191956-A2 | MALODOR COUNTERACTING COMPOSITION | SKYESTER, INC. (US) | 2024-09-19 | — | — | WO | disclosed |
| CN-114949255-B | Polysarcosine modified gold nano vesicle and preparation method and application thereof | 南京工业大学 | 2023-08-18 | — | — | CN | disclosed |
| EP-3253752-B1 | [9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]ISOQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO | NEUROCRINE BIOSCIENCES INC (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-1351953-A1 | QUINOLINE DERIVATIVES AS NK-3 ANTAGONISTS | GlaxoSmithKline S.p.A. (IT) | 2003-10-15 | — | — | EP | disclosed |
| WO-2002044165-A1 | QUINOLINE DERIVATIVES AS NK-3 ANTAGONISTS | GLAXOSMITHKLINE SPA (IT) | 2002-06-06 | — | — | WO | disclosed |
| EP-0277092-A1 | Therapeutic system for slightly soluble active ingredients | CIBA-GEIGY AG (CH) | 1988-08-03 | — | — | EP | disclosed |